Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


2 AIDS Res Hum Retroviruses
1 BMC Immunol
6 Clin Infect Dis
7 HIV Med
1 Int J Cancer
1 Int J Dermatol
4 J Acquir Immune Defic Syndr
1 J Infect Dis
2 J Virol
2 Lancet
1 Lancet Infect Dis
1 Neurology
2 Pediatr Infect Dis J
1 PLoS Comput Biol
10 PLoS One
2 PLoS Pathog
2 Proc Natl Acad Sci U S A


  1. DRAK D, Mcmanus H, Vickers T, Heron JE, et al
    Renal impairment in a large-scale HIV pre-exposure prophylaxis implementation cohort.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96341.
    >> Share

  2. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    >> Share

  3. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared to HIV-unexposed.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96338.
    >> Share

  4. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Multimorbidity networks associated with frailty among middle aged and older people with HIV.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96337.
    >> Share

  5. WANG M, Boeke CE, Rioja MR, Maparo T, et al
    Feasibility and impact of near-point-of-care integrated TB/HIV testing in Malawi and Zimbabwe.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96342.
    >> Share

    AIDS Res Hum Retroviruses

  6. YAN J, Luo L, Han J, Yan D, et al
    Comparing non-invasive predictors of neurosyphilis among syphilis patients with and without HIV co-infection based on the real-world diagnostic criteria: a single-centre, retrospective cohort study in China.
    AIDS Res Hum Retroviruses. 2021 Jul 27. doi: 10.1089/AID.2021.0085.
    >> Share

  7. WELLER KG, Evans LK, Shinagawa A, Murtagh A, et al
    Missed Testing Opportunities Among HIV-Positive Adults in a Community Emergency Department.
    AIDS Res Hum Retroviruses. 2021 Jul 27. doi: 10.1089/AID.2020.0229.
    >> Share

    BMC Immunol

  8. KOLOU M, Poda A, Diallo Z, Konou E, et al
    Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.
    BMC Immunol. 2021;22:48.
    >> Share

    Clin Infect Dis

  9. KAY AW, Sandoval M, Mtetwa G, Mkhabela M, et al
    Vikela Ekhaya: a novel, community-based, tuberculosis contact management program in a high burden setting.
    Clin Infect Dis. 2021 Jul 24. pii: 6327779. doi: 10.1093.
    >> Share

  10. YAPA HM, Kim HY, Petoumenos K, Post FA, et al
    CD4+ T-cell count at antiretroviral therapy initiation in the "treat all" era in rural South Africa: an interrupted time series analysis.
    Clin Infect Dis. 2021 Jul 26. pii: 6328536. doi: 10.1093.
    >> Share

  11. FORD N, Chiller T
    CD4 cell count: a critical tool in the HIV response.
    Clin Infect Dis. 2021 Jul 26. pii: 6328294. doi: 10.1093.
    >> Share

  12. MOODLEY N, Velen K, Saimen A, Zakhura N, et al
    Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa.
    Clin Infect Dis. 2021 Jul 27. pii: 6329140. doi: 10.1093.
    >> Share

  13. MATHAD JS, Savic R, Britto P, Jayachandran P, et al
    Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
    Clin Infect Dis. 2021 Jul 29. pii: 6330598. doi: 10.1093.
    >> Share

  14. ELLIS RJ, Paolillo E, Saloner R, Heaton RK, et al
    Higher comorbidity burden predicts worsening neurocognitive trajectories in people with HIV.
    Clin Infect Dis. 2021 Jul 30. pii: 6331334. doi: 10.1093.
    >> Share

    HIV Med

  15. ROBERTS O, Kinvig H, Owen A, Lamorde M, et al
    In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel.
    HIV Med. 2021 Jul 30. doi: 10.1111/hiv.13136.
    >> Share

  16. DIEZ C, Del Romero-Raposo J, Mican R, Lopez JC, et al
    COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study.
    HIV Med. 2021 Jul 29. doi: 10.1111/hiv.13145.
    >> Share

  17. GIROMETTI N, Delpech V, McCormack S, Khawam J, et al
    The success of HIV combination prevention: The Dean Street model.
    HIV Med. 2021 Jul 29. doi: 10.1111/hiv.13149.
    >> Share

  18. LAWAL IO, Orunmuyi AT, Popoola GO, Mokoala KMG, et al
    Immune reconstitution inflammatory syndrome-associated Graves disease in HIV-infected patients: clinical characteristics and response to radioactive iodine therapy.
    HIV Med. 2021 Jul 30. doi: 10.1111/hiv.13148.
    >> Share

  19. FABBIANI M, Rossetti B, Ciccullo A, Oreni L, et al
    Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
    HIV Med. 2021 Jul 27. doi: 10.1111/hiv.13146.
    >> Share

  20. CRAWFORD D, Allan B, Cogle A, Brown G, et al
    Client-led care in HIV: perspectives from community and practice.
    HIV Med. 2021;22 Suppl 1:3-14.
    >> Share

  21. OKHAI H, Sabin CA, Haag K, Sherr L, et al
    Menopausal status, age and management among women living with HIV in the UK.
    HIV Med. 2021 Jul 26. doi: 10.1111/hiv.13138.
    >> Share

    Int J Cancer

  22. VAN DER ZEE RP, Meijer CJLM, Cuming T, Kreuter A, et al
    Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive men by immunohistochemical markers p16, Ki-67, HPV-E4, and DNA methylation markers.
    Int J Cancer. 2021 Jul 26. doi: 10.1002/ijc.33748.
    >> Share

    Int J Dermatol

  23. OLOMUKORO CN, Dlova NC, Sibanda W, Chateau AV, et al
    Mucocutaneous diseases in the combined antiretroviral therapy era: prevalence and spectrum in HIV seropositive children and adolescents in Durban, South Africa.
    Int J Dermatol. 2021 Jul 26. doi: 10.1111/ijd.15735.
    >> Share

    J Acquir Immune Defic Syndr

  24. CHEN YT, Duncan DT, Del Vecchio N, Timmins L, et al
    COVID-19 related stressors, sex behaviors, and HIV status neutral care among Black men who have sex with men and transgender women in Chicago, USA.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95838.
    >> Share

  25. HAKIM AJ, Tippett Barr BA, Kinchen S, Musuka G, et al
    Progress toward the 90-90-90 HIV targets in Zimbabwe and identifying those left behind.
    J Acquir Immune Defic Syndr. 2021 Jul 24. pii: 00126334-900000000-95837.
    >> Share

  26. SCHLENKER NW, Irvin NA, Galetto GG, Dashler GM, et al
    Identifying Missed Opportunities in the Prevention of Acute HIV Infection - The Need to Provide Pre-Exposure Prophylaxis Referrals to Emergency Department Patients with Increased Risk for Acquiring HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 27. pii: 00126334-900000000-95836.
    >> Share

  27. LYSS SB, Zhang T, Oster AM
    HIV Diagnoses Among Persons Who Inject Drugs, by Urban-Rural Classification - United States, 2010-2018.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95839.
    >> Share

    J Infect Dis

  28. GIL RM, Freeman T, Mathew T, Kullar R, et al
    The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers.
    J Infect Dis. 2021 Jul 29. pii: 6330600. doi: 10.1093.
    >> Share

    J Virol

  29. RAHMAN K, Compton AA
    The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes.
    J Virol. 2021 Jul 28:JVI0068021. doi: 10.1128/JVI.00680.
    >> Share

  30. RICANA CL, Johnson MC
    An infectious Rous Sarcoma Virus Gag mutant that is defective in nuclear cycling.
    J Virol. 2021 Jul 28:JVI0064821. doi: 10.1128/JVI.00648.
    >> Share


  31. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    >> Share

    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    >> Share

    Lancet Infect Dis

    Uganda's Sexual Offences Bill-a step backwards.
    Lancet Infect Dis. 2021;21:920.
    >> Share


  34. CHISHIMBA L, Chomba M, Zimba S, Mwansa T, et al
    Clinical Reasoning: An Unexpected Response to Therapy in a Patient With HIV and Focal Seizures.
    Neurology. 2021 Jul 26. pii: WNL.0000000000012536.
    >> Share

    Pediatr Infect Dis J

  35. NTULI N, Wadula J, Nakwa F, Thomas R, et al
    Characteristics and Outcomes of Neonates With Blood Stream Infection Due to Listeria monocytogenes.
    Pediatr Infect Dis J. 2021 Jul 22. pii: 00006454-900000000-95731.
    >> Share

  36. CRESSEY TR, Abbassi M, Lallemant M, Indolfi G, et al
    Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult Formulations.
    Pediatr Infect Dis J. 2021 Jul 27. pii: 00006454-900000000-95720.
    >> Share

    PLoS Comput Biol

  37. CODY JW, Ellis-Connell AL, O'Connor SL, Pienaar E, et al
    Mathematical modeling of N-803 treatment in SIV-infected non-human primates.
    PLoS Comput Biol. 2021;17:e1009204.
    >> Share

    PLoS One

  38. KENGNE-NDE C, Tejiokem MC, Orne-Gliemann J, Melingui B, et al
    Couple oriented counselling improves male partner involvement in sexual and reproductive health of a couple: Evidence from the ANRS PRENAHTEST randomized trial.
    PLoS One. 2021;16:e0255330.
    >> Share

  39. CONNELLY JT, Andama A, Grant BD, Ball A, et al
    Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
    PLoS One. 2021;16:e0254156.
    >> Share

  40. DEFANTE FERRETO LE, Guedes S, Braz Pauli F, Soligo Rovani S, et al
    Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
    PLoS One. 2021;16:e0255173.
    >> Share

  41. FERNANDEZ CRUZ AL, Chen CM, Sanford R, Collins DL, et al
    Multimodal neuroimaging markers of variation in cognitive ability in older HIV+ men.
    PLoS One. 2021;16:e0243670.
    >> Share

  42. SAZ J, Dalmau-Bueno A, Meulbroek M, Pujol F, et al
    Use of fourth-generation rapid combined antigen and antibody diagnostic tests for the detection of acute HIV infection in a community centre for men who have sex with men, between 2016 and 2019.
    PLoS One. 2021;16:e0255065.
    >> Share

  43. ROUSSEAU RK, Szadkowski L, Kovacs CM, Saikali MF, et al
    Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression.
    PLoS One. 2021;16:e0254149.
    >> Share

  44. STELMACH RD, Rabkin M, Abo K, Ahoba I, et al
    Financial burdens of HIV and chronic disease on people living with HIV in Cote d'Ivoire: A cross-sectional out-of-pocket expenditure study.
    PLoS One. 2021;16:e0255074.
    >> Share

  45. CHIMOYI L, Hoffmann CJ, Hausler H, Ndini P, et al
    HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysis.
    PLoS One. 2021;16:e0254975.
    >> Share

  46. LORENZETTI L, Swann M, Martinez A, O'Regan A, et al
    Using financial diaries to understand the economic lives of HIV-positive pregnant women and new mothers in PMTCT in Zomba, Malawi.
    PLoS One. 2021;16:e0252083.
    >> Share

  47. HOPKINS KL, Jaffer M, Hlongwane KE, Otwombe K, et al
    Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    PLoS One. 2021;16:e0255124.
    >> Share

    PLoS Pathog

  48. KERVEVAN J, Bouteau A, Lanza JS, Hammoudi A, et al
    Targeting human langerin promotes HIV-1 specific humoral immune responses.
    PLoS Pathog. 2021;17:e1009749.
    >> Share

  49. BISWAS A, Zhou D, Fiches GN, Wu Z, et al
    Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination.
    PLoS Pathog. 2021;17:e1009764.
    >> Share

    Proc Natl Acad Sci U S A

  50. Correction for Madan et al., Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

  51. MEIJERS M, Vanshylla K, Gruell H, Klein F, et al
    Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016